A5050249455- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Neuroendocrine Tumor Research Advances
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Surgical Treatments
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Gastric Cancer Management and Outcomes
- Pancreatic function and diabetes
- Surgical Simulation and Training
- Gastrointestinal disorders and treatments
- Liver Disease and Transplantation
- Colorectal and Anal Carcinomas
- Hospital Admissions and Outcomes
- Esophageal and GI Pathology
- Liver Disease Diagnosis and Treatment
- Lung Cancer Research Studies
- Genetic factors in colorectal cancer
- Organ Transplantation Techniques and Outcomes
- Renal cell carcinoma treatment
- Colorectal Cancer Screening and Detection
- Neuroblastoma Research and Treatments
University of California, San Francisco
2004-2025
Shinshu University
2024-2025
Hiroshima University
2025
UCSF Helen Diller Family Comprehensive Cancer Center
2019-2024
University of Tokyo Hospital
2024
Graduate School USA
2020
The University of Tokyo
2001-2020
European Neuroendocrine Tumor Society
2019
Johns Hopkins University
2010-2017
Johns Hopkins Medicine
2010-2017
Hospital readmission is emerging as a quality indicator by the state, federal, and private payors with goal of denying payment for select readmissions.We designed study to measure rate, cost, risk factors hospital after colorectal surgery.We reviewed commercial health insurance records 10,882 patients who underwent surgery over 7-year period (2002-2008).All undergoing colon and/or rectal resection ages 18 64 were included.The 30-day 90-day rates, number readmissions per patient, median...
BACKGROUND Molecular biomarkers offer the potential for refining prognostic determinants in patients undergoing cancer surgery. Among with colorectal cancer, KRAS and BRAF are important biomarkers, but their role surgical therapy liver metastases is unknown. In this study, incidence significance of mutations were determined (CRLM). METHODS analysis was performed on 202 surgery CRLM between 2003 2008. Tumor samples analyzed somatic using sequencing (KRAS, codon12/13, BRAF, V600E). The...
Prognosis after surgery for pancreatic ductal adenocarcinoma (PDAC) is typically reported from the date of surgery. Survival estimates, however, are dynamic and may change based on time already survived. The authors sought to assess conditional survival among a large cohort patients who underwent resection PDAC.Between 1970 2008, 1822 PDAC with curative intent were identified. Kaplan-Meier Cox regression analyses performed validate established predictors survival, results compared 2-year...
IMPORTANCE It is not known whether hospital and surgeon volumes have an association with readmission among patients undergoing pancreatoduodenectomy.To evaluate patient-, surgeon-, hospital-level factors associated readmission.Retrospective cohort study using the Surveillance, Epidemiology, End Results (SEER)-Medicare data cases diagnosed from January 1, 1998, to December 31, 2005, followed up until 2007. Population-based cancer registry were linked Medicare for corresponding patients. A...
Splenic artery embolization (SAE) improves hepatic (HA) flow in liver transplant (OLT) recipients with so-called splenic steal syndrome. We propose that SAE actually HA by reducing the buffer response (HABR). Patient 1: On postoperative day (POD) 1, Doppler ultrasonography (US) showed patent vasculature resistive index (RI) of 0.8. POD 4, aminotransferases rose dramatically; his RI was 1.0 no diastolic flow. Octreotide begun, but on 5 US reverse signal distal branches. After SAE, markedly...
We sought to quantify the use of and analyze factors predictive receipt surgical therapy for early hepatocellular carcinoma (HCC).The incidence HCC is increasing, options have expanded, but has not been examined in a modern cohort.A retrospective cohort study was performed using data from 1998-2007 Surveillance, Epidemiology, End Results-Medicare linked database. Data were analyzed patients 66 years age older with (tumors ≤5 cm without metastatic disease, nodal metastasis, extrahepatic...
Purpose The choice between liver transplantation (LT), resection (LR), and radiofrequency ablation (RFA) as initial therapy for early hepatocellular carcinoma (HCC) is controversial, yet little known about how surgeons choose individual patients. We sought to quantify the impact of both clinical factors surgeon specialty on surgical decision making in HCC by using conjoint analysis. Methods Surgeons with an interest surgery were invited complete a Web-based survey including 10 case...